Valuation: China Isotope & Radiation Corporation

Market Cap 4.66B 5.39B 688M 605M 563M 517M 971M 65.95B 983M 6.69B 2.61B 32.57B 2.58B 2.53B 113B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 4.78B 5.53B 705M 620M 577M 530M 995M 67.64B 1.01B 6.86B 2.68B 33.4B 2.65B 2.59B 115B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
06/07 China Isotope to Form JV With Associate MT
03/07 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
19/06 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
19/06 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
27/05 China Isotope Proposes Auditor Change MT
27/05 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
28/03 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
28/03 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
28/03 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
20/03 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
14/03 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
14/03 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
02/03 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
1 day+2.43%
1 week+0.36%
Current month-3.66%
1 month-2.54%
3 months-10.46%
6 months-25.20%
Current year-16.53%
1 week 16.29
Extreme 16.29
17.99
1 month 16.29
Extreme 16.29
18.7
Current year 16.29
Extreme 16.29
24.28
1 year 15.2
Extreme 15.2
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
29.95
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 02/08/2024
Corporate Secretary - 30/08/2024
Corporate Secretary - 30/08/2024
Director TitleAgeSince
Director/Board Member 57 22/02/2017
Director/Board Member 54 28/06/2019
Director/Board Member 54 30/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.43%+0.36%+2.43%+17.41% 671M
-1.26%-1.76%+228.60%+288.85% 19.54B
+1.14%-3.15%-43.58%-26.61% 9.39B
+3.06%+3.48%+49.19%+26.41% 6.82B
-0.76%+6.25%+213.66%-24.36% 5.87B
-2.79%+4.01%-17.77%-23.56% 5.61B
+0.71%+0.45%-42.24% - 4.39B
+7.13%-8.59%+83.94%+103.71% 4.19B
+0.51%-3.23%-25.88%-30.10% 4.03B
+1.43%-0.99%-20.82%-44.29% 2.66B
Average +1.16%-2.74%+42.75%+31.94% 6.32B
Weighted average by Cap. +0.43%-3.24%+87.98%+93.68%

Financials

2024 2025
Net sales 7.57B 8.77B 1.12B 983M 915M 841M 1.58B 107B 1.6B 10.88B 4.25B 52.97B 4.2B 4.11B 183B 7.19B 8.32B 1.06B 933M 869M 798M 1.5B 102B 1.52B 10.32B 4.03B 50.26B 3.98B 3.9B 174B
Net income 407M 471M 60.05M 52.79M 49.14M 45.13M 84.74M 5.76B 85.86M 584M 228M 2.84B 225M 221M 9.83B 327M 379M 48.35M 42.51M 39.57M 36.34M 68.23M 4.64B 69.13M 470M 184M 2.29B 182M 178M 7.91B
Net Debt -109M -126M -16.09M -14.14M -13.16M -12.09M -22.7M -1.54B -23M -156M -61.11M -762M -60.39M -59.08M -2.63B 119M 138M 17.55M 15.43M 14.36M 13.19M 24.77M 1.68B 25.09M 171M 66.67M 831M 65.88M 64.46M 2.87B
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
27/07/26 HKD 16.86 +2.43% 70,800
24/07/26 HKD 16.46 -4.02% 45,000
23/07/26 HKD 17.15 +1.72% 33,800
22/07/26 HKD 16.86 -1.00% 83,600
21/07/26 HKD 17.03 +0.18% 54,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock